SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Altered regional homogeneity in Parkinson's disease with mild cognitive impairment: a resting-state fMRI study.

Front Psychol · 2026-05-08

DOI: 10.3389/fpsyg.2026.1816245PMID: 42183505

Open accessresearch-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

BackgroundTo explore changes in regional homogeneity (ReHo) of brain function in patients with Parkinson's disease with mild cognitive impairment (PD-MCI) using resting-state functional magnetic resonance imaging (rs-fMRI), and to analyze the correlation between ReHo values in differential brain regions and cognitive function, so as to identify potential neuroimaging biomarkers for PD-MCI.MethodsA total of 43 patients with PD were enrolled and divided into the PD-MCI group (n = 23) and the PD with normal cognitive function (PD-NC) group (n = 20). Additionally, 20 healthy controls (HC) were recruited. The ReHo method was used to evaluate differences in functional consistency of brain regions, and the Montreal Cognitive Assessment (MoCA) scale was employed to assess cognitive function. Further, a correlation analysis was performed between the ReHo values of each brain region and MoCA scores in patients with PD-MCI and PD-NC and the receiver operating characteristic (ROC) curve was used to evaluate the discriminative efficacy of these brain regions for PD-MCI.ResultsCompared with the PD-NC group, the PD-MCI group showed significantly decreased ReHo values in the right middle frontal gyrus and right superior frontal gyrus (t = -3.3113, -4.1326, both p t = 4.9059, 2.9759, both p r = -0.5597, -0.6239, p r = 0.5690, 0.5296, p ConclusionFunctional abnormalities in brain regions including the right middle frontal gyrus, right superior frontal gyrus, right cerebellar lobule VIII, left inferior temporal gyrus, and right fusiform gyrus are closely associated with the occurrence and development of PD-MCI. ReHo indicators in these regions are promising potential neuroimaging biomarkers for auxiliary diagnosis and monitoring the progression of PD-MCI.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.